Related Experiment Video
Updated: Jun 26, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
The evolving process of European combination product review, Part II
1Donawa Consulting, Rome, Italy. medonawa@donawa.com
Abstract:
A new European guideline on drug-eluting stents (DES) introduces for the first time detailed information that European drug authorities should review concerning the medicinal substance that is incorporated into this type of drug-device combination product. Part I of this article discussed European requirements that apply to DES. This article discusses the new guideline, other stent guidelines, and the evolving process of drug-device regulatory review in Europe.
More Related Videos
05:47Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
Published on: August 29, 2025
09:16Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Predicting Products: Substitution vs. Elimination
The following factors can influence the mechanisms competing against each other:
Review and Preview
Review and Preview
Percentiles are a type of fractile that partition data into...
Clinical Trials: Overview
Drug Products: Biologics, Biosimilars and Interchangeables